Literature DB >> 12187112

Pure red cell aplasia preceding malignant lymphoma in a renal transplant patient.

A A Kiykim1, M Arici, B Altun, Y Erdem, U Yasavul, C Turgan, S Caglar.   

Abstract

Malignant disorders are one of the major causes of morbidity and mortality in transplant patients. We present herein a renal transplant recipient with malignant lymphoma which preceded by pure red cell aplasia (PRCA). Acquired PRCA is a rare hematologic disorder in renal transplant recipients. It has been associated with a variety of disorders of immunologic dysfunction and neoplasms, exposure to drugs and toxins, infectious diseases, pregnancy and severe nutritional deficiency. This is the first case with PRCA preceding the malign lymphoma in a renal transplant patient. Treatment of lymphoma and lymphoma-related humoral and cellular changes or other undefined effects that may be related to therapy may be responsible of the resolving of PRCA in this patient. In this regard, renal transplant patients with acquired PRCA, must be closely followed for an underlying neoplastic disorder. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12187112     DOI: 10.1159/000064456

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  [Clinical analysis of 32 patients with acquired pure red cell aplasia].

Authors:  J F Chen; J M Kang; Y F Zhang; M F Wang; C X Dong; L Y Wang; L P Guo; L H Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

2.  Persistent anemia in a patient with diffuse large B cell lymphoma: pure red cell aplasia associated with latent Epstein-Barr virus infection in bone marrow.

Authors:  Hwa Jung Sung; Seok Jin Kim; Ji Hye Lee; Goeun Lee; Kyung A Lee; Chul Won Choi; Byung Soo Kim; Jun Suk Kim
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.